Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-01-31
1997-12-23
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514569, 514573, 514554, 514555, 560119, 562501, C07C 5911
Patent
active
057008337
ABSTRACT:
The present invention provides novel isocarbacyclin derivatives useful for search and study of prostacyclin receptor and as a therapeutic drug for central nervous system diseases, which derivatives are expressed by the ##STR1## an appropriate amount, and R.sup.2 an alkylene group.!
REFERENCES:
patent: 4307112 (1981-12-01), Gandolfi et al.
M. Suzuki et al., "The Japanese Journal of Pharmacology", vol. 67,
Chemical Abstracts 101:90626q, "Synthesis of dl-9(O)-methanoprostaglandin-l1", 1984.
Chemical Abstracts 99:19471Ou, "Carbaprostacyclins", 1983.
Chemical Abstracts 95:168649d, "Bicyclooctane Derivatives", 1979.
Hazato Atsuo
Langstrom Bengt
Suzuki Masa-aki
Watanabe Yasuyoshi
Hazato Atsuo
Krass Frederick
Research Developement Corporation of Japan
LandOfFree
Isocarbacyclin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isocarbacyclin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isocarbacyclin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1803122